Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol vs Expectant Management for Intra-uterine Residua
NCT01134926Phase 2Terminated
- Sponsor
- Emek Medical Center
- Start
- Jun 2010
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of misoprostol in retained products of conception (RPOC), sponsored by Emek Medical Center. Started Jun 2010; status: terminated.
02
Drugs
misoprostol
03
Conditions
retained products of conception (RPOC)
Beyond the preview
Go deeper on NCT01134926.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01134926.